Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Estrone. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 known ✓ | P03372 | 2/20 | 0.89 |
| ▸ | STS | P08842 | 8/20 | 0.89 |
| ▸ | HSD17B1 | P14061 | 4/20 | 0.89 |
| ▸ | CYP19A1 | P11511 | 4/20 | 0.89 |
| ▸ | LMNA | P02545 | 2/20 | 0.89 |
| ▸ | MAPT | P10636 | 2/20 | 0.89 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.89 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.89 |
| ▸ | AKR1B10 | O60218 | 1/20 | 0.89 |
| ▸ | SHBG | P04278 | 1/20 | 0.89 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.89 |
| ▸ | PGR | P06401 | 1/20 | 0.89 |
| ▸ | SERPINA6 | P08185 | 1/20 | 0.89 |
| ▸ | AR | P10275 | 1/20 | 0.89 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.89 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.89 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.89 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.89 |
| ▸ | SNCA | P37840 | 1/20 | 0.89 |
| ▸ | HTR2B | P41595 | 1/20 | 0.89 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Estrone SCHEMBL6693553 | 0.99 | STS (0.91) | STSHSD17B1CYP19A1LMNAMAPT | |
| Estrone SCHEMBL22847 | 0.99 | STS (0.91) | STSHSD17B1CYP19A1LMNAMAPT | |
| Estrone SCHEMBL22551313 | 0.98 | STS (0.89) | STSHSD17B1CYP19A1LMNAMAPT | |
| Estrone SCHEMBL669802 | 0.98 | STS (0.89) | STSHSD17B1CYP19A1LMNAMAPT | |
| Estrone SCHEMBL8209868 | 0.95 | CYP19A1 (0.97) | STSHSD17B1CYP19A1LMNAMAPT | |
| Estrone SCHEMBL8209870 | 0.95 | CYP19A1 (0.97) | STSHSD17B1CYP19A1LMNAMAPT | |
| Estrone SCHEMBL628643 | 0.94 | STS (0.87) | STSHSD17B1CYP19A1LMNAMAPT | |
| Estrone SCHEMBL157262 | 0.94 | CYP19A1 (1.00) | STSHSD17B1CYP19A1LMNAMAPT | |
| Estrone SCHEMBL5028951 | 0.94 | CYP19A1 (1.00) | STSHSD17B1CYP19A1LMNAMAPT | |
| Estrone SCHEMBL12054811 | 0.94 | CYP19A1 (1.00) | STSHSD17B1CYP19A1LMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1780634-A | Methods and compositions using gonadotropin hormone releasing hormone | DEBIOPHARM SA (CH) | 2006-05-31 | — | — | CN | claimed |
| CN-102215901-B | Devices and methods for treating and/or preventing diseases | COMBINENT BIOMEDICAL SYSTEMS I | 2014-12-03 | — | — | CN | disclosed |
| CN-102497855-B | Multi-layered gradient vaginal ring | POPULATION COUNCIL INC | 2013-12-25 | — | — | CN | disclosed |
| CN-102497855-A | Multi-layered gradient vaginal ring | POPULATION COUNCIL INC | 2012-06-13 | — | — | CN | disclosed |
| CN-102215901-A | Devices and methods for treating and/or preventing diseases | COMBINENT BIOMEDICAL SYSTEMS I | 2011-10-12 | — | — | CN | disclosed |
| CN-1780634-A | Methods and compositions using gonadotropin hormone releasing hormone | DEBIOPHARM SA (CH) | 2006-05-31 | — | — | CN | disclosed |
| US-5610180-A | TOCOPHEROL AND CHOLESTEROL DERIVATIVES, CYTOPROTECTIVE AGENTS | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 1997-03-11 | — | — | US | disclosed |
| US-5336485-A | Administering cholestane phthalates, succinates or sulfates before administering tacrine | CENTER FOR INNOVATIVE TECHNOLOGY (US) | 1994-08-09 | — | — | US | disclosed |
| US-5198432-A | Cytoprotective agents | CENTER FOR INNOVATIVE TECHNOLOGY (US) | 1993-03-30 | — | — | US | disclosed |